Ideas and analysis shaping decisions across the industry

Explore Topics

The Average Customer Is a Lie You Can’t Afford

RESEARCH METHODS

The Average Customer Is a Lie You Can’t Afford

Strategies built for the HCP or the patient speak to an average that behaves like no one. Zain Raj explains why demographic segmentation falls short and what makes a segmentation commercially useful: clear priorities, activation built in, and regular revisiting.

Oct 14, 2026

READ MORE →
If Your Evidence Lands as Noise, It Isn’t Evidence Yet.

PHARMA BRANDING

If Your Evidence Lands as Noise, It Isn’t Evidence Yet.

Strong clinical evidence can still land as noise. Zain Raj explains why adding more proof or more message testing won’t fix a message that isn’t landing, and why the real fix is translating evidence into a story HCPs can hold and repeat.

Oct 14, 2026

READ MORE →
Stop Mapping the Journey. Find Where It Breaks.

HCP+PATIENT INSIGHTS

Stop Mapping the Journey. Find Where It Breaks.

Most patient journey maps document every touchpoint but treat them all as equal. Zain Raj explains why the moments that decide adoption are the one or two where behavior tips, and why finding those breaks matters more than building a better map.

Oct 14, 2026

READ MORE →
The Customer Has Changed. Pharma’s Commercial Model Hasn’t.

PHARMA BRANDING

The Customer Has Changed. Pharma’s Commercial Model Hasn’t.

Pharma modernized its sales force, channels, and analytics but kept one assumption: the physician is the customer. Zain Raj argues the real customer is now a decision system of payers, pathways, health systems, and patients, and that commercial advantage depends on mapping where power lives.

Sep 22, 2026

READ MORE →
Better Science Doesn’t Sell Itself

HCP+PATIENT INSIGHTS

Better Science Doesn’t Sell Itself

Physicians don't adopt better treatments just because the evidence says they should. Explore why superior clinical data alone fails to change prescribing behavior — and what actually moves it: understanding the friction, habit, and structural barriers standing in the way.

Sep 19, 2026

READ MORE →
Everyone Launches. Almost No One Lands.

PHARMA BRANDING

Everyone Launches. Almost No One Lands.

Most pharma launches fail on positioning, not science. Competitive data shows where every player stands, but finding defensible ground takes judgment, not analysis. Zain Raj argues speed and insight, not more data, are what separate launches that land from launches that merely happen.

Sep 12, 2026

READ MORE →

Get insights in your inbox

Subscribe to receive the latest thinking on life sciences, strategy, and innovation.

    Ready to move faster?

    Let's discuss how we can accelerate your strategic decisions.